This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Don't play games on remedies notification, Australian official warns dealmakers

By James Panichi ( May 22, 2025, 06:14 GMT | Insight) -- Dealmakers planning to horse trade with the regulator by offering “piecemeal” remedies under Australia’s new mandatory and suspensory merger regime could see their deals delayed as the review escalates to an in-depth, “phase 2” probe, Australia’s top antitrust official has warned. Gina Cass-Gottlieb said at an event in Sydney that while there were provisions in the law for extensions to be granted when remedies are offered, it was nonetheless in the dealmakers’ interest for merger parties to put forward “clear-cut remedy solutions” as early as possible in phase 1.Dealmakers planning to horse trade with the regulator by offering “piecemeal” remedies under Australia’s new mandatory and suspensory merger regime could see their deals delayed as the review escalates to an in-depth, “phase 2” probe, Australia’s top antitrust official has warned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login